Skip to main content
Recall Canary
Fexofenadine Hydrochloride Tablets 180 mg
← Back to all recalls
DRUG RECALLLOW

Fexofenadine Hydrochloride Tablets 180 mg

Ohm Laboratories is recalling 180 mg Fexofenadine Hydrochloride tablets due to failed impurities and degradation specifications.

What to do

Stop using the medication and contact your pharmacist or healthcare provider for further guidance.

Recalled
Listed
Updated
Recall No.
D-0654-2026
Agency
FDA
Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Recall ID
99110
Status
ONGOING

Recall at a glance

Quantity recalled
9,048 bottles

Why it was recalled

Ohm Laboratories is recalling Fexofenadine Hydrochloride Tablets, 180 mg, due to failed impurities and degradation specifications. The affected product is packaged in 150-count bottles.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Fexofenadine Hydrochloride Tablets, USP

Lot code
DNG0283A, 2027, DNF0922A, DNF0923B, 2026
Strength
180 mg
NDC / UPC
NDC 66336-561-30

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other Impurity or Degradation recalls

Other recent recalls from SUN PHARMACEUTICAL INDUSTRIES INC

All recalls from SUN PHARMACEUTICAL INDUSTRIES INC

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-07-14 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification